pharmaphorum

JANUARY 28, 2021

One of these markets is the insulin market. Up until now, the insulin market has experienced little competition and, as a result, prices have soared over the years. More than 30 million Americans have diabetes and another 88 million are at risk of developing it. But, that will soon be changing, due to biosimilars.

Marketing 104

Marketing Insulin HR Production 104

The Pharma Data

AUGUST 3, 2021

Revenue growth was 12 percent when excluding effects of 2020 COVID-related stocking patterns, revenue from COVID-19 antibodies and recent business development. The trial compared tirzepatide to insulin glargine in adults with type 2 diabetes and increased cardiovascular risk. Business Development/Other Developments.

Antibody 52

Antibody Sales Production Development 52

XTalks

AUGUST 2, 2023

They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. It contains the antiviral medications nirmatrelvir and ritonavir. billion in 2022. billion in 2022.

Sales 98

Sales Manufacturing FDA Approval Life Science 98